Precigen, Inc.

As of June 30, 2026, Precigen Inc carries a market capitalization of 1.78B, placing it among publicly traded companies globally. Its enterprise value stands at 1.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Precigen Inc's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Precigen Inc has 358.01M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 22.77, and the price-to-book ratio stands at 46.74.

These figures are as of June 30, 2026. The EV/Sales ratio of 24.46 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.84B versus a market cap of 1.78B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Precigen Inc maintains a current ratio of 4.58, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 225.69, indicating elevated leverage, while an interest coverage ratio of -3.64 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -115.88, reflecting losses generated across the asset base. The company generates approximately 481,721.28 in revenue per employee across its workforce of 155.75, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Precigen Inc's stock has gained approximately 67.06% over the past 52 weeks. The 50-day moving average sits at 6.36, while the 200-day moving average is 4.53.

Over the twelve months ended June 30, 2026, Precigen Inc generated 75.03M in revenue and converted that into -138.04M in net income, yielding earnings per share of -0.39. EBITDA reached -30.95M, while operating income came in at -34.57M.

As of June 30, 2026, Precigen Inc holds 33.44M in cash and equivalents against 86.08M in total debt, resulting in a net debt position of 67.88M. Total book value stands at 38.14M, with working capital of 91.93M providing operational flexibility.

Precigen Inc produced -99.93M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -925,192.10 in capital expenditures, free cash flow totaled -100.85M - equivalent to -0.29 per share.

Over the twelve months ended June 30, 2026, Precigen Inc posted a gross margin of 90.67, reflecting its pricing power and cost economics. The operating margin of -46.08 and net profit margin of -183.98 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 53.16 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -5.67: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.54, meaning Precigen Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Precigen Inc has an Altman Z-Score of -11.20, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.